Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_assertion type Assertion NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_head.
- NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_assertion wasGeneratedBy ECO_0000203 NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_provenance.
- NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_assertion wasDerivedFrom befree-20140225 NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_provenance.
- NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_assertion SIO_000772 19222642 NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_provenance.
- NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_assertion evidence source_evidence_literature NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_provenance.
- NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_assertion description "[Deletion of 9q34 and aberrant expression of SOCS-1 are associated with poor prognosis in CML patients with different phases of the disease under interferon therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925599.RASUETtZ4EzjQAF-CS8N3fbXJuEQodBWpHPsgv0TY2Exw130_provenance.